|
- Metoclopramide in the Treatment of Diabetic Gastroparesis
Risk factors for extrapyramidal reactions from metoclopramide include diabetes mellitus Unfortunately, this is also a risk factor for developing gastroparesis and metoclopramide is the only FDA
- Long-Acting Injectables Curb Schizophrenia Readmission - Medscape
There was no significant between-group difference in the use of anticholinergic medications to treat extrapyramidal symptoms (22% in the LAI group and 31% in the oral group) despite the LAI group
- Depression, Extrapyramidal Symptoms, Dementia and an . . . - Medscape
The extrapyramidal symptoms have disappeared Introduction The diagnosis of Parkinson's disease (PD) is, most of the times, clinical with sensitivity of 88% and specificity 78%
- Ending Long-term Anticholinergic Use: It Can Be Done - Medscape
Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients with serious mental
- Forget the Tremor: These Symptoms Come First in Parkinson’s - Medscape
Damage to extrapyramidal reflexes means patients may be unable to catch themselves when off balance Additional Early Signs Depression and anxiety : Often overlooked or misdiagnosed as primary
- Positive Phase 3 Results for Antipsychotic in Schizophrenia - Medscape
The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal EMERGENT-2 trial
- Olanzapine Associated With Lower Rate of Extrapyramidal . . . - Medscape
Oct 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large prospective trial
- Novel Drug Safe, Effective for Acute Schizophrenia - Medscape
“The drug is effective, and it has a very mild safety profile, with no metabolic side effects and limited extrapyramidal effects,” study co-investigator Maciej Wieczorek, MD, CEO of Celon
|
|
|